These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30576500)

  • 1. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
    Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
    Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
    Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
    Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
    Ezeh U; Pisarska MD; Azziz R
    Hum Reprod; 2022 Mar; 37(3):553-564. PubMed ID: 35048126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.
    Ezeh U; Chen IY; Chen YH; Azziz R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):e2408-20. PubMed ID: 32382742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
    Cassar S; Misso ML; Hopkins WG; Shaw CS; Teede HJ; Stepto NK
    Hum Reprod; 2016 Nov; 31(11):2619-2631. PubMed ID: 27907900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    Hum Reprod; 2020 May; 35(5):1168-1177. PubMed ID: 32325487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting energy expenditure in women with polycystic ovary syndrome.
    Tosi F; Rosmini F; Gremes V; Lucarini F; Zandonà M; Zanolin ME; Fiers T; Kaufman JM; Moghetti P
    Hum Reprod; 2024 Aug; 39(8):1794-1803. PubMed ID: 38867472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
    Tosi F; Bonora E; Moghetti P
    Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
    Veltman-Verhulst SM; Goverde AJ; van Haeften TW; Fauser BC
    Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.